Elderly Dependent Patients With Non Small Cell Lung Cancer (NSCLC)

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

September 30, 2006

Study Completion Date

March 31, 2010

Conditions
Non Small Cell Lung Cancer
Interventions
DRUG

TARCEVA

Tarceva (150 mg) is a pill you take once a day -- every day -- to help treat non-small cell lung cancer.

DRUG

Gemzar

GEMZAR by mixing it into a solution and giving it through a needle into a vein-called intravenous infusion (IV). This will take about 30 minutes

Trial Locations (23)

13100

Site 12, Aix-en-Provence

13274

Site 06, Marseille

13695

Site 27, Martigues

14000

Site 43, Caen

20200

Site 05, Bastia

24019

Site 19, Périgueux

35033

Site 20, Rennes

45032

Site 42, Orléans

51092

Site 02, Reims

60021

Site 22, Beauvais

69655

Site 11, Villefranche-sur-Saône

75012

Site 26, Paris

76233

Site 17, Rouen

76503

Site 32, Elbeuf

77108

Site 01, Meaux

78157

Site 41, Le Chesnay

78200

Site 25, Mantes-la-Jolie

83300

Site 07, Draguignan

83800

Site 14, Toulon

94010

Site 33, Créteil

08000

Site 30, Charleville-Mézières

05000

Site 04, Gap

Unknown

Site 00, Limoges

All Listed Sponsors
lead

Groupe Francais De Pneumo-Cancerologie

OTHER

NCT00419042 - Elderly Dependent Patients With Non Small Cell Lung Cancer (NSCLC) | Biotech Hunter | Biotech Hunter